Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Allergy and Clinical Immunology: In Practice

• Publication date

  2017-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jaip.2017.10.004PMID 29153881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adherence to COPD management guidelines in general practice? A review of the literature

  2018cited by this paper
• Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort

  2017cited by this paper
• Blood Eosinophil Count and Outcomes in Severe Uncontrolled Asthma: A Prospective Study.

  2017cited by this paper
• Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions

  2017cited by this paper
• Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts

  2017cited by this paper
• Predictors of re-exacerbation after an index exacerbation of chronic obstructive pulmonary disease in the REDUCE randomised clinical trial.

  2017cited by this paper
• Prediction models for exacerbations in patients with COPD

  2017cited by this paper
• Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline Counts.

  2017cited by this paper
• Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD

  2016cited by this paper
• Blood eosinophils as a marker of response to inhaled corticosteroids in COPD

  2016cited by this paper
• Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.

  2016cited by this paper
• Eosinophils in COPD: the Janus of phenotyping response to therapy?

  2016cited by this paper
• Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.

  2016cited by this paper
• Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD

  2016cited by this paper
• Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD

  2016cited by this paper
• A year in the life of German patients with COPD: the DACCORD observational study

  2016cited by this paper
• Predictors of frequent exacerbations in (ex)smoking and never smoking adults with severe asthma.

  2016cited by this paper
• Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast.

  2016cited by this paper
• Characteristics and Outcomes of HEDIS-Defined Asthma Patients with COPD Diagnostic Coding.

  2016cited by this paper
• Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD

  2016cited by this paper
• Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease.

  2015cited by this paper
• Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patients

  2015cited by this paper
• Outpatient Chronic Obstructive Pulmonary Disease Management: Going for the GOLD.

  2015cited by this paper
• The association of blood eosinophil counts to future asthma exacerbations in children with persistent asthma.

  2015cited by this paper
• Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD

  2015cited by this paper
• Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.

  2015cited by this paper
• Relationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening in chronic obstructive pulmonary disease

  2015cited by this paper
• Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.

  2015cited by this paper
• High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.

  2014cited by this paper
• Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis

  2014cited by this paper
• Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns

  2014cited by this paper
• High blood eosinophil count is associated with more frequent asthma attacks in asthma patients.

  2014cited by this paper
• Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.

  2014cited by this paper
• Trends in the Use, Sociodemographic Correlates, and Undertreatment of Prescription Medications for Chronic Obstructive Pulmonary Disease among Adults with Chronic Obstructive Pulmonary Disease in the United States from 1999 to 2010

  2014cited by this paper
• Eosinophilic inflammation in COPD: prevalence and clinical characteristics

  2014cited by this paper
• Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma.

  2013cited by this paper
• Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis

  2013cited by this paper
• The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease

  2012cited by this paper
• Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients

  2012cited by this paper
• Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.

  2012cited by this paper
• Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.

  2012cited by this paper
• The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease

  2011cited by this paper
• Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.

  2011cited by this paper
• Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data

  2011cited by this paper
• Step-up care improves impairment in uncontrolled asthma: an administrative data study.

  2010cited by this paper
• Susceptibility to exacerbation in chronic obstructive pulmonary disease.

  2010cited by this paper
• The 2007 GOLD Guidelines: A Comprehensive Care Framework

  2009cited by this paper
• Counting, analysing and reporting exacerbations of COPD in randomised controlled trials

  2007cited by this paper
• Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial

  2007cited by this paper
• Global burden of COPD: systematic review and meta-analysis

  2006cited by this paper
• Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice.

  2006cited by this paper
• Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.

  2006cited by this paper
• Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data.

  2006cited by this paper
• Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment

  2006cited by this paper
• How well do the HEDIS asthma inclusion criteria identify persistent asthma?

  2005cited by this paper
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease

  2005cited by this paper
• COPD exacerbations: definitions and classifications

  2003cited by this paper
• Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis.

  1998cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper

• Eosinophilic endotype as a predictor of NIV success in COPD exacerbation with acute respiratory failure

  2026cites this paper
• Comparative analysis of clinical outcomes and short-term treatment response of sputum microbiome between eosinophilic and non-eosinophilic COPD acute exacerbation.

  2026cites this paper
• Prognostic Value of Biomarkers in Chronic Obstructive Pulmonary Disease: A Comprehensive Review

  2025cites this paper
• Blood Eosinophil Stability Predicts Clinical Outcomes in Hospitalized Patients with Acute Exacerbations of COPD

  2025cites this paper
• Peripheral Blood Eosinophil as a Predictor of Clinical Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study From a Tertiary Care Center in South India

  2025cites this paper
• Research Progress on Biomarkers of Frequent Acute Exacerbations of Chronic Obstructive Pulmonary Disease

  2025cites this paper
• The Value of FeNO and Peripheral Blood Eosinophils in Assessing Airway Eosinophilic Inflammation in Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease

  2025cites this paper
• A Delphi Consensus Project to Capture Greek Experts’ Opinion on the Position of Triple Therapies in COPD: Why, When and to Whom

  2025cites this paper
• Chronic obstructive pulmonary disease, biological agents and small molecules: where do we stand?

  2025cites this paper
• IgE Guided Use of ICS in Patients with Stable COPD: A Real-World Observational Study

  2025cites this paper
• Clinical Characteristics and 2-Year Outcomes of Chronic Obstructive Pulmonary Disease Patients With High Blood Eosinophil Counts: A Population-based Prospective Cohort Study in China.

  2024cites this paper
• Anti-Eosinophil Biologics in Chronic Respiratory Diseases

  2024cites this paper
• Advances in Blood Biomarkers in Chronic Obstructive Pulmonary Disease

  2024cites this paper
• Mucus Plugs as Precursors to Exacerbation and Lung Function Decline in COPD Patients.

  2024cites this paper
• Identification of symptom clusters and change trajectories in patients with acute exacerbation of chronic obstructive pulmonary disease

  2024cites this paper
• A Phase 3 Trial of Dupilumab for People With Chronic Obstructive Pulmonary Disease and Elevated Peripheral Blood Eosinophil Counts.

  2024cites this paper
• Blood eosinophils in chronic obstructive pulmonary disease: A potential biomarker

  2023cites this paper
• Association of Blood Inflammatory Biomarkers with Clinical Outcomes in Patients with AECOPD: An 8-Year Retrospective Study in Beijing

  2023cites this paper
• Relationship between Serum Indexes and Lung Function in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

  2023cites this paper
• Asthma Chronic Obstructive Pulmonary Disease Overlap

  2023cites this paper
• Time-Updated Phenotypic Guidance of Corticosteroids and Antibiotics in COPD: Rationale, Perspective and a Proposed Method

  2023cites this paper
• Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis

  2023cites this paper
• Heterogeneity of asthma–chronic obstructive pulmonary disease (COPD) overlap from a cohort of patients with severe asthma and COPD

  2023cites this paper
• COPD treatment - a conceptual review based on critical endpoints.

  2023cites this paper
• Longitudinal changes in forced expiratory volume in 1 s in patients with eosinophilic chronic obstructive pulmonary disease

  2022cites this paper
• The Role of Dual Bronchodilation and the Conscientious Use of Inhaled Corticosteroid in COPD

  2022cites this paper
• Stability of Blood Eosinophils in COPD with Multiple Acute Exacerbations Within 1 Year and Its Relationship with Prognosis

  2022influential citation
• Circulating eosinophil levels and lung function decline in stable chronic obstructive pulmonary disease: a retrospective longitudinal study

  2022cites this paper
• Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD Exacerbation

  2022cites this paper
• Early Treatment with IL-5/IL-5R antibodies in patients with severe eosinophilic Asthma and COPD

  2022cites this paper
• Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD

  2022cites this paper
• Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review

  2022cites this paper
• Clinical Characteristics and Outcome Related to Blood Eosinophilic Chronic Obstructive Pulmonary Disease (COPD) Patients

  2022cites this paper
• Elevated Peripheral Blood Eosinophils during Acute Exacerbation of Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO

  2021cites this paper
• Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis

  2021cites this paper
• Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis

  2021cites this paper
• Biomarkers in Chronic Obstructive Pulmonary Disease: Emerging Roles of Eosinophils and Procalcitonin

  2021cites this paper
• Identifying COPD in routinely collected electronic health records: a systematic scoping review

  2021cites this paper
• Treatment Response Biomarkers in Asthma and COPD

  2021cites this paper
• Elevated Peripheral Blood Eosinophils (PBE) During Acute Exacerbation

  2021cites this paper
• T2 Biomarkers as Predictors of Exacerbations of Chronic Obstructive Pulmonary Disease.

  2021cites this paper
• COPD_A_294333 1755..1770

  2021cites this paper
• Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease

  2020cites this paper
• Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis

  2020cites this paper
• Plasma eosinophil count and patient-centered events in chronic obstructive pulmonary disease in real-life clinical practice

  2020cites this paper
• Fractional Exhaled Nitric Oxide is Associated with the Severity of Stable COPD

  2020cites this paper
• COPD_A_268018 2869..2877

  2020influential citation
• COPD_A_235054 107..116

  2020cites this paper
• Novel Perspectives Regarding the Pathology, Inflammation, and Biomarkers of Acute Respiratory Distress Syndrome

  2020cites this paper
• Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life.

  2020cites this paper
• A new predictor to determine the exacerbation and treatment of chronic obstructive pulmonary disease: eosinophil/neutrophil ratio.

  2020cites this paper
• How Do Innate Immune Cells Contribute to Airway Remodeling in COPD Progression?

  2020cites this paper
• The Role of the Pharmacist in Optimizing Outcomes With Roflumilast, a PDE4 Inhibitor for the Treatment of COPD

  2020cites this paper
• Blood Eosinophil and Risk of Exacerbation in Chronic Obstructive Pulmonary Disease Patients: A Retrospective Cohort Analysis

  2020influential citation
• Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs.

  2020cites this paper
• Clinical characteristics of neutrophilic, eosinophilic and mixed-type exacerbation phenotypes of COPD.

  2020cites this paper
• Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population

  2019cites this paper
• Clinical And Economic Burden Of Eosinophilic COPD In A Large Retrospective US Cohort

  2019influential citation
• Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy

  2019cites this paper
• The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization

  2019influential citation
• Etude de l’intérêt de l’éosinophilie sanguine au cours des exacerbations aiguës sévères de bronchopneumopathie chronique obstructive (BPCO) dans un centre tunisien

  2019cites this paper
• Clinical And Economic Burden Of Eosinophilic COPD In A Large Retrospective US Cohort

  2019cites this paper
• The Importance of Neutrophil to Lymphocyte Ratio and Peripheral Blood Eosinophilia in Chronic Obstructive Pulmonary Disease Patients with Acute Exacerbation: Recent Studies

  2019cites this paper
• Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population

  2019cites this paper
• Clinical burden of illness among patients with severe eosinophilic COPD

  2019cites this paper
• Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts

  2019cites this paper
• Blood eosinophils and C-reactive protein as prognostic factors in severe chronic obstructive pulmonary disease exacerbations

  2019cites this paper
• exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts

  2019cites this paper
• exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts

  2019cites this paper
• The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization

  2019influential citation
• Associations Between Individual Characteristics and Blood Eosinophil Counts in Adults with Asthma or COPD.

  2019cites this paper
• Machine Learning Characterization of COPD Subtypes: Insights from the COPDGene Study.

  2019cites this paper
• Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy

  2019cites this paper
• The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization

  2019influential citation
• Plasma Eosinophil Count and Patient-Centered Events in Chronic Obstructive Pulmonary Disease in Real-Life Clinical Practice.

  2019cites this paper
• Clinical burden of illness among patients with severe eosinophilic COPD

  2019cites this paper
• IL-33 blockade impacts mediators of persistence and exacerbation in a model of chronic airway inflammation.

  2019cites this paper
• Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance

  2019cites this paper
• Advances in Asthma, ACO, and Related Biologics in 2018.

  2019cites this paper
• Absolute blood eosinophil counts to guide inhaled corticosteroids therapy among patients with COPD, GOLD 2019: Systematic review and meta-analysis of evidence.

  2019cites this paper
• Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease

  2018cites this paper
• Clinical features, bacteriology of endotracheal aspirates and treatment outcomes of patients with chronic obstructive pulmonary disease and community-acquired pneumonia in an intensive care unit in Taiwan with an emphasis on eosinophilia versus non-eosinophilia: a retrospective case–control study

  2018cites this paper
• Prevention of copd exacerbations. Focus on dual bronchodilators

  2018cites this paper
• Профилактика обострений хронической обструктивной болезни легких. В фокусе – двойные комбинации бронхолитиков

  2018cites this paper